Article Details

Why Immix Biopharma Shares Are Surging Today? - Benzinga

Retrieved on: 2022-12-14 18:01:49

Tags for this article:

Click the tags to see associated articles and topics

Why Immix Biopharma Shares Are Surging Today? - Benzinga. View article details on hiswai:

Excerpt

Immix Biopharma Inc (NASDAQ: IMMX) announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 (formerly HBI0101).

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up